Alternatives to calcineurin inhibition in renal transplantation: belatacept, the first co-stimulation blocker
出版年份 2010 全文链接
标题
Alternatives to calcineurin inhibition in renal transplantation: belatacept, the first co-stimulation blocker
作者
关键词
-
出版物
Immunotherapy
Volume 2, Issue 5, Pages 625-636
出版商
Future Medicine Ltd
发表日期
2010-09-29
DOI
10.2217/imt.10.57
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A Randomized, Multicenter Study of Steroid Avoidance, Early Steroid Withdrawal or Standard Steroid Therapy in Kidney Transplant Recipients
- (2010) F. Vincenti et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Sotrastaurin, a Novel Small Molecule Inhibiting Protein Kinase C: First Clinical Results in Renal-Transplant Recipients
- (2010) K. Budde et al. AMERICAN JOURNAL OF TRANSPLANTATION
- A Phase III Study of Belatacept Versus Cyclosporine in Kidney Transplants from Extended Criteria Donors (BENEFIT-EXT Study)
- (2010) A. Durrbach et al. AMERICAN JOURNAL OF TRANSPLANTATION
- A Phase III Study of Belatacept-based Immunosuppression Regimens versus Cyclosporine in Renal Transplant Recipients (BENEFIT Study)
- (2010) F. Vincenti et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Inducing CTLA-4-Dependent Immune Regulation by Selective CD28 Blockade Promotes Regulatory T Cells in Organ Transplantation
- (2010) N. Poirier et al. Science Translational Medicine
- Memory T-cell-specific therapeutics in organ transplantation
- (2009) Andrew J Page et al. Current Opinion in Organ Transplantation
- Abatacept Does Not Induce Direct Gene Expression Changes in Antigen-Presenting Cells
- (2009) Julie A. Carman et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Dendritic Cells Secrete the Immunosuppressive HLA-G Molecule upon CTLA4-Ig Treatment: Implication in Human Renal Transplant Acceptance
- (2009) R. Bahri et al. JOURNAL OF IMMUNOLOGY
- Alefacept promotes co-stimulation blockade based allograft survival in nonhuman primates
- (2009) Tim A Weaver et al. NATURE MEDICINE
- Assessment of Belatacept-Mediated Costimulation Blockade Through Evaluation of CD80/86-Receptor Saturation
- (2009) Robert Latek et al. TRANSPLANTATION
- Monitoring of the Immunomodulatory Effect of CP-690,550 by Analysis of the JAK/STAT Pathway in Kidney Transplant Patients
- (2009) Monique E. Quaedackers et al. TRANSPLANTATION
- What's Next in the Pipeline
- (2008) F. Vincenti et al. AMERICAN JOURNAL OF TRANSPLANTATION
- The Effect of Costimulatory and Interleukin 2 Receptor Blockade on Regulatory T Cells in Renal Transplantation
- (2008) J. A. Bluestone et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Chronic allograft dysfunction: can we use mammalian target of rapamycin inhibitors to replace calcineurin inhibitors to preserve graft function?
- (2008) Ravinder K Wali et al. Current Opinion in Organ Transplantation
- Interaction of human PD-L1 and B7-1
- (2008) Manish J. Butte et al. MOLECULAR IMMUNOLOGY
- HLA-Mismatched Renal Transplantation without Maintenance Immunosuppression
- (2008) Tatsuo Kawai et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tolerance and Chimerism after Renal and Hematopoietic-Cell Transplantation
- (2008) John D. Scandling et al. NEW ENGLAND JOURNAL OF MEDICINE
- Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation
- (2008) Y. Onishi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CTLA-4 Control over Foxp3+ Regulatory T Cell Function
- (2008) K. Wing et al. SCIENCE
- Abatacept modulates human dendritic cell-stimulated T-cell proliferation and effector function independent of IDO induction
- (2007) Patricia M. Davis et al. CLINICAL IMMUNOLOGY
- CTLA-4 disrupts ZAP70 microcluster formation with reduced T cell/APC dwell times and calcium mobilization
- (2007) Helga Schneider et al. EUROPEAN JOURNAL OF IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started